HI
IMCR icon

Harbour Investments’s Immunocore IMCR Stock Holding History

Harbour Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,033
Closed -$35.9K – 4726
2025
Q4 		$35.9K Buy
1,033
+388
+60% +$13.7K ﹤0.01% 2119
2025
Q3 		$23.4K Buy
+645
New +$21.9K ﹤0.01% 2258
2021
Q4 		– Sell
-25
Closed -$1K – 3147
2021
Q3 		$1K Hold
25
– – ﹤0.01% 3528
2021
Q2 		$1K Hold
25
– – ﹤0.01% 3577
2021
Q1 		$1K Buy
+25
New +$1.11K ﹤0.01% 3409

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Harbour Investments's IMCR Position: Q1 2026 in Review

Harbour Investments sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 1,033 shares — an estimated $35.9K sold.

Harbour Investments first reported a position in IMCR in Q1 2021 and held it in 5 quarters. The position peaked at $35.9K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Harbour Investments reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Harbour Investments sold 1,033 Immunocore shares in Q1 2026, an estimated $35.9K.
  • Harbour Investments first reported a position in Immunocore in Q1 2021 and held it in 5 quarters.
  • Harbour Investments's Immunocore position peaked at $35.9K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.